LOX and pulmonary emphysema: Increased LOX activity is associated with fibrotic diseases such as lung and liver fibrosis and atherosclerosis [1], whereas decreased LOX activity is associated with lathyritic agent-induced emphysema in animal models and with disorders of copper metabolism like Menkes syndrome.